These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 17624267)

  • 1. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
    Zhang Y; Chen B; Hou XH; Guan GJ; Liu G; Liu HY; Li XG
    Chin Med J (Engl); 2007 Jun; 120(11):988-95. PubMed ID: 17624267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
    Chen B; Zhang Y; Liu G; Guan GJ; Hou XH; Li XG; Liu JL
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):540-5. PubMed ID: 18649770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil and valsartan inhibit podocyte apoptosis in streptozotocin-induced diabetic rats.
    Lv W; Zhang Y; Guan G; Li P; Wang J; Qi D
    Pharmacology; 2013; 92(3-4):227-34. PubMed ID: 24158161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of angiotensin II receptor antagonist on rat podocyte injury in early diabetic nephropathy].
    Long HB; Zhong J; Wei LB; Zhou WD; Xu ZZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):505-8. PubMed ID: 17545045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
    Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
    Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
    Zhou G; Cheung AK; Liu X; Huang Y
    Clin Sci (Lond); 2014 May; 126(10):707-20. PubMed ID: 24195695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of aliskiren and valsartan in mice with diabetic nephropathy.
    Wang W; Qiu L; Howard A; Solis N; Li C; Wang X; Kopp JB; Levi M
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):384-95. PubMed ID: 25031296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
    Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
    Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic rats.
    Sanajou D; Ghorbani Haghjo A; Argani H; Roshangar L; Ahmad SNS; Jigheh ZA; Aslani S; Panah F; Rashedi J; Mesgari Abbasi M
    J Physiol Biochem; 2018 Aug; 74(3):467-478. PubMed ID: 29948786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of ginsenoside Rgl on the expression of TNF-alpha and MCP-1 in rats with diabetic nephropathy].
    Zhang LN; Xie XS; Zuo C; Fan JM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):466-71. PubMed ID: 19627007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes.
    Wu YG; Lin H; Qi XM; Wu GZ; Qian H; Zhao M; Shen JJ; Lin ST
    Int Immunopharmacol; 2006 Mar; 6(3):445-53. PubMed ID: 16428080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy.
    Wu Y; Dong J; Yuan L; Liang C; Ren K; Zhang W; Fang F; Shen J
    Cytokine; 2008 Oct; 44(1):85-91. PubMed ID: 18725182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E
    Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of podocyte ultrastructure and expression of podocyte-associated molecules in rats with diabetic nephropathy].
    Chen LP; Zhou QL; Peng WS; Wu XY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):620-5. PubMed ID: 17767053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
    Wang S; Li Y; Huang YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes.
    Utimura R; Fujihara CK; Mattar AL; Malheiros DM; Noronha IL; Zatz R
    Kidney Int; 2003 Jan; 63(1):209-16. PubMed ID: 12472785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local delivery of angiotensin II receptor blockers into the kidney passively attenuates inflammatory reactions during the early phases of streptozotocin-induced diabetic nephropathy through inhibition of calpain activity.
    Kamal F; Yanakieva-Georgieva N; Piao H; Morioka T; Oite T
    Nephron Exp Nephrol; 2010; 115(3):e69-79. PubMed ID: 20424485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valsartan inhibited HIF-1α pathway and attenuated renal interstitial fibrosis in streptozotocin-diabetic rats.
    Tang L; Yi R; Yang B; Li H; Chen H; Liu Z
    Diabetes Res Clin Pract; 2012 Jul; 97(1):125-31. PubMed ID: 22377232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined MMF and insulin therapy prevents renal injury in experimental diabetic rats.
    Wu X; Zha D; Xiang G; Zhang B; Xiao SY; Jia R
    Cytokine; 2006 Dec; 36(5-6):229-36. PubMed ID: 17337203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.